Literature DB >> 8542021

Molecular genetics of H, Se, Lewis and other fucosyltransferase genes.

R Mollicone1, A Cailleau, R Oriol.   

Abstract

Seven human fucosyltransferase genes have been cloned and registered in the Genome Data Base (GDB) as FUT1 to FUT7. According to their acceptor specificity, two main groups of enzymes can be distinguished. The alpha-2-fucosyltransferases: FUT1 (H) of red cells and vascular endothelium and FUT2 (Se) of exocrine secretions. The alpha-3-fucosyltransferases: FUT3 (Lewis) of exocrine secretions; FUT4 (myeloid) of white cells and brain; FUT5 whose tissue distribution has not been defined as yet; FUT6 (plasma) present in plasma, renal proximal tubules and hepatocytes; FUT7 (leukocyte) found in neutrophils. A high DNA sequence homology has been detected among the genes within each of these two groups, while no homology has been detected between the genes of the two groups. Point mutations responsible of inactivating genetic polymorphisms have been found for FUT1, FUT2, FUT3 and FUT6, while FUT4 and FUT7 seem to be genetically monomorphic. FUT4 has been detected in all tissues of 5 to 10 weeks old human embryos suggesting that it may play a role in development. FUT7 is a candidate for the control of the synthesis of the receptors of selectin mediated cell adhesion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8542021     DOI: 10.1016/s1246-7820(05)80089-8

Source DB:  PubMed          Journal:  Transfus Clin Biol        ISSN: 1246-7820            Impact factor:   1.406


  17 in total

1.  Urine oligosaccharide pattern in patients with hyperprolactinaemia.

Authors:  Bertil Ekman; Jeanette Wahlberg; Eva Landberg
Journal:  Glycoconj J       Date:  2015-08-15       Impact factor: 2.916

Review 2.  Blood group antigens: molecules seeking a function?

Authors:  P Greenwell
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

3.  Unravelling the biochemical basis of blood group ABO and Lewis antigenic specificity.

Authors:  W T Morgan; W M Watkins
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

Review 4.  Current Perspectives in ABO-Incompatible Kidney Transplant.

Authors:  Federica Maritati; Claudia Bini; Vania Cuna; Francesco Tondolo; Sarah Lerario; Valeria Grandinetti; Marco Busutti; Valeria Corradetti; Gaetano La Manna; Giorgia Comai
Journal:  J Inflamm Res       Date:  2022-05-25

Review 5.  Strategies to overcome the ABO barrier in kidney transplantation.

Authors:  Georg A Böhmig; Andreas M Farkas; Farsad Eskandary; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2015-09-01       Impact factor: 28.314

6.  Norwalk virus-like particles bind specifically to A, H and difucosylated Lewis but not to B histo-blood group active glycosphingolipids.

Authors:  Jonas Nilsson; Gustaf E Rydell; Jacques Le Pendu; Göran Larson
Journal:  Glycoconj J       Date:  2009-12       Impact factor: 2.916

7.  Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis.

Authors:  Wen-Wei Chang; Chien Hsin Lee; Peishan Lee; Juway Lin; Chun-Wei Hsu; Jung-Tung Hung; Jin-Jin Lin; Jyh-Cherng Yu; Li-en Shao; John Yu; Chi-Huey Wong; Alice L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-06       Impact factor: 11.205

Review 8.  Toward universal donor blood: Enzymatic conversion of A and B to O type.

Authors:  Peter Rahfeld; Stephen G Withers
Journal:  J Biol Chem       Date:  2019-12-02       Impact factor: 5.157

9.  Golgi enzymes that synthesize plant cell wall polysaccharides: finding and evaluating candidates in the genomic era.

Authors:  R Perrin; C Wilkerson; K Keegstra
Journal:  Plant Mol Biol       Date:  2001-09       Impact factor: 4.335

10.  Identification of neutrophil granule glycoproteins as Lewis(x)-containing ligands cleared by the scavenger receptor C-type lectin.

Authors:  Sarah A Graham; Aristotelis Antonopoulos; Paul G Hitchen; Stuart M Haslam; Anne Dell; Kurt Drickamer; Maureen E Taylor
Journal:  J Biol Chem       Date:  2011-05-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.